$CBIS "The release of CBIS' Unisex Suppository Regimen is an important milestone as we build the company's portfolio of cannabinoid-based medicines. While this regimen is intended for men and women, we expect to release gender-specific suppositories and other products in the near future," stated Mr. Raymond C. Dabney, CBIS' President & CEO and Co-founder.
(0)
(0)
Consider all my posts my opinion and not advice to buy or sell anything. I post on stocks I own or am considering owning. Do your own DD!